(UEF5) UBS MSCI Emerging Markets - Overview
Etf: Emerging, Markets, Equities, Esg
Dividends
| Dividend Yield | 2.51% |
| Yield on Cost 5y | 1.18% |
| Yield CAGR 5y | 16.90% |
| Payout Consistency | 94.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.5% |
| Relative Tail Risk | -6.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 18.24 |
| Character TTM | |
|---|---|
| Beta | 0.203 |
| Beta Downside | 0.477 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.41% |
| CAGR/Max DD | 0.72 |
Description: UEF5 UBS MSCI Emerging Markets January 16, 2026
The UBS MSCI Emerging Markets Socially Responsible UCITS A-dis (XETRA: UEF5) is a Germany-domiciled ETF that tracks the Morningstar EM Total Market Ex-US Dollar Net Return Index (NR USD). It provides exposure to a broad basket of emerging-market equities while applying MSCI’s ESG screening to exclude firms with poor sustainability scores.
Based on the latest fund factsheet (as of Q4 2025), the ETF carries an expense ratio of 0.20 % and manages roughly €1.1 billion in assets, with the top five holdings accounting for about 7 % of the portfolio (e.g., Tencent, Samsung, and Taiwan Semiconductor). Sector weighting is tilted toward information technology (≈ 30 %) and consumer discretionary (≈ 20 %), reflecting the growth-oriented nature of the underlying markets.
Key macro drivers for the fund’s performance include: (1) commodity price trends, since many EM economies are net exporters of raw materials; (2) China’s GDP growth trajectory, which influences demand for electronic components and consumer goods; and (3) the stance of US Federal Reserve policy, as higher rates can trigger capital outflows from emerging markets, pressuring local currencies and equity valuations.
If you want a deeper, data-driven breakdown of the fund’s risk-adjusted returns and ESG impact metrics, a quick look at ValueRay’s analytical dashboard can help you validate whether the current valuation aligns with your risk-return objectives.
What is the price of UEF5 shares?
Over the past week, the price has changed by +1.40%, over one month by +3.47%, over three months by +8.11% and over the past year by +25.62%.
Is UEF5 a buy, sell or hold?
What are the forecasts/targets for the UEF5 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 18.1 | 9.1% |
UEF5 Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.28b EUR (2.28b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.28b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.28b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.66% (E(2.28b)/V(2.28b) * Re(6.66%) + (debt-free company))
Discount Rate = 6.66% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)